Literature DB >> 19282311

Role of contextual factors in health-related quality of life in ankylosing spondylitis.

V S Gordeev1, W P Maksymowych, S M A A Evers, A Ament, L Schachna, A Boonen.   

Abstract

BACKGROUND: In the bio-psycho-social model of health, the role of contextual factors, either environmental or personal, is recognised.
OBJECTIVE: To assess the impact of a number of contextual factors on self-reported disease-specific and generic health-related quality of life in patients with ankylosing spondylitis (AS).
METHODS: 522 patients with AS from Canada and Australia completed a postal questionnaire including sociodemographic variables, disease activity (Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)) function (Bath Ankylosing Spondylitis Functional Index (BASFI)) health-related quality of life (ASQoL and EQ-5D) and Rheumatoid Attitudes Index Helplessness Subscale. The contribution of contextual factors (nationality, ethnicity, marital status, education, employment and helplessness) in addition to functioning and disability (BASDAI and BASFI) to health-related quality of life was analysed using multivariate regression analyses. Interactions between contextual variables were explored.
RESULTS: Contextual factors explained 37% and 47% of the variance in EQ-5D and ASQoL, respectively. Helplessness and employment were the most important contextual factors. Their role was independent of the strong effect of disease activity (BASDAI) and functional limitations (BASFI). When ASQoL was the outcome, an interaction was seen between employment and education and when EQ-5D was the outcome, an interaction was seen between helplessness and education.
CONCLUSIONS: Of the contextual factors explored in this study, helplessness and employment had an important and independent contribution to health-related quality of life. In patients with lower education, the effect of not being employed on ASQoL and the effect of helplessness on EQ-5D were stronger. Contextual factors, especially helplessness and employment, should receive more attention when interpreting data on health-related quality of life.

Entities:  

Mesh:

Year:  2010        PMID: 19282311     DOI: 10.1136/ard.2008.100164

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Evaluating the reliability of Persian version of ankylosing spondylitis quality of life (ASQoL) questionnaire and related clinical and demographic parameters in patients with ankylosing spondylitis.

Authors:  Sasan Fallahi; Ahmad Reza Jamshidi; Katayoon Bidad; Mostafa Qorbani; Mahdi Mahmoudi
Journal:  Rheumatol Int       Date:  2013-10-30       Impact factor: 2.631

2.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 9 International classification of functioning, disability and health (ICF)].

Authors:  U Kiltz; W Mau; U Repschläger; E Böhle; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

3.  Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.

Authors:  U Kiltz; D van der Heijde; A Boonen; A Cieza; G Stucki; M A Khan; W P Maksymowych; H Marzo-Ortega; J Reveille; S Stebbings; C Bostan; J Braun
Journal:  Ann Rheum Dis       Date:  2014-01-07       Impact factor: 19.103

4.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

5.  Reliability and Validity of Turkish Version of Short Form of the Social Role Participation Questionnaire in Patients With Ankylosing Spondylitis.

Authors:  Yesim Akyol; Yasemin Ulus; Yüksel Terzi; Ayhan Bilgici; Ömer Kuru
Journal:  Arch Rheumatol       Date:  2018-04-11       Impact factor: 1.472

6.  Tripterygium wilfordii Hook F. in the treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a clinical trial.

Authors:  Lun Wang; Liang Gong; Xinlu Zhang; Yihan Cao; Piaopiao Long; Wen Zhang; Xiaofeng Zeng; Chen Li
Journal:  Clin Rheumatol       Date:  2021-01-03       Impact factor: 2.980

7.  Psychometric properties and utility of the Responses to Positive Affect questionnaire (RPA) in a sample of people with bipolar disorder.

Authors:  Jannis T Kraiss; Peter M Ten Klooster; Melissa Chrispijn; Anja W M M Stevens; Ralph W Kupka; Ernst T Bohlmeijer
Journal:  J Clin Psychol       Date:  2019-06-25

8.  Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis.

Authors:  Tamar F Brionez; Shervin Assassi; John D Reveille; Thomas J Learch; Laura Diekman; Michael M Ward; John C Davis; Michael H Weisman; Perry Nicassio
Journal:  Arthritis Res Ther       Date:  2009-12-07       Impact factor: 5.156

9.  Anxiety and depression correlate with disease and quality-of-life parameters in Chinese patients with ankylosing spondylitis.

Authors:  Xujuan Xu; Biyu Shen; Aixian Zhang; Jingwei Liu; Zhanyun Da; Hong Liu; Zhifeng Gu
Journal:  Patient Prefer Adherence       Date:  2016-05-20       Impact factor: 2.711

10.  Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life.

Authors:  Maike Imkamp; Valéria Lima Passos; Annelies Boonen; Suzanne Arends; Maxime Dougados; Robert Landewé; Sofia Ramiro; Filip Van den Bosch; Desirée van der Heijde; Freke R Wink; Anneke Spoorenberg; Astrid van Tubergen
Journal:  RMD Open       Date:  2018-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.